The CD44+/CD24−/low phenotype is more associated with basal-like breast cancers, while the ALDH1+ cells are more common in HER2-overexpression (HER2-OE) and basal/epithelial breast cancers19,20. Here, ERBB2 is linked to breast carcinoma.